PERSPECTA

News from every angle

← Back to headlines

Novo Nordisk Wins US FDA Approval for Once-Weekly Insulin Awiqli for Type 2 Diabetes

Novo Nordisk has secured US FDA approval for its once-weekly insulin Awiqli, expanding its presence in diabetes care and offering a new treatment option for type 2 diabetes.

27 Mar, 11:09 — 27 Mar, 11:09
PostShare

Sources

Showing 1 of 2 sources
seeking-alphaMixed2d ago

Novo Nordisk wins FDA approval for once-weekly insulin

Read full article →

Coverage Timeline

First report: berlingske · 27 Mar, 07:56Full coverage: 2 · 3hWindow: 3h
Left-leaningCenterRight-leaning
berlingske27 Mar, 07:56First to report

Novo får amerikansk godkendelse til insulin på ugebasis

3h later
seeking-alpha27 Mar, 11:09Latest update

Novo Nordisk wins FDA approval for once-weekly insulin

Related Stories

Expert Discusses Health Implications of Late-Night Eating

50m ago

Icelandic Hospital CEO Reflects on Epidemic Response

1h ago

Bristol Myers Drug Shows Promise for Rare Pediatric Heart Condition

1h ago

Violent Fire Breaks Out in German Club, 750 Evacuated

1h ago